跳至主要内容
临床试验/NCT03699761
NCT03699761招募中不适用

Evaluation of Pelvic Peritonization in Robotic or Laparoscopic Low Anterior Resection for Rectal Cancer

Southwest Hospital, China1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Grade III-IV complications

研究概览

简要总结

A randomized controlled clinical trial to compare the short and long outcomes of low anterior resection for middle-low rectal cancer with or without pelvic peritonization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Matching the diagnostic criteria of rectal adenocarcinoma
  • Laparoscopic or robotic radical surgery for rectal cancer
  • Preoperative TNM staging T1-3N0-2M0
  • No history of malignant tumors by preoperative examination
  • Middle and low rectal cancer
  • Tumor size of 4 cm or less
  • ASA 1-3 scores
  • Written informed consent by the patient
  • The patient is willing to randomize to any group

排除标准

  • Previous abdominal surgery
  • Past malignant tumor history
  • Preoperative examination suggests distant metastasis
  • Be participating or have participated in other clinical studies related to rectal cancer surgery within 6 months
  • Emergency operation
  • Elimination criteria
  • The tumor is confirmed to be T4b during the operation or other tumors are found to be combined with other tumors during the operation
  • The anastomosis is located above the peritoneum reflex
  • Intraoperative conversion to laparotomy
  • Change the surgical method to perform Miles or Hartmann surgery
  • Postoperative pathologically confirmed non-adenocarcinoma
  • The patient asked to withdraw

结局指标

主要结局

Grade III-IV complications

时间窗: 30 days

The rate of grade III-IV complication according to Clavien-Dindo classification after low anterior resection

次要结局

  • Operation time(1 day)
  • Treatment cost(30 days)
  • LARS(12 months)
  • Detection of other inflammation markers(7 days)
  • Estimated blood loss(1 day)
  • Detection of inflammation markers(7 days)
  • Overall complication rate(30days)
  • Readmission rate(30 days)
  • Rate of reoperation(30 days)
  • Hospital time(30 days)
  • The rate of anastomotic leakage(30 days)
  • Postoperative bleeding(7 days)
  • Intestinal obstruction(30 days)
  • Acute inflammatory Response(7 days)

研究者

发起方
Southwest Hospital, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tang Bo

Principal Investigator

Southwest Hospital, China

研究点 (1)

Loading locations...

相似试验